Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Roberts

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|April 3, 2012
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trialJason D Roberts, George A Wells, Michel R Le May, et al.
Heart Rhythm|March 7, 2015
Comparison of radionuclide angiographic synchrony analysis to echocardiography and magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathyColleen J Johnson, Jason D Roberts, Jameze H James, et al.
The Biochemical Journal|July 26, 2023
RyR2 C-terminal truncating variants identified in patients with arrhythmic phenotypes exert a dominant negative effect through formation of wildtype-truncation heteromersShanshan Tian, Xiaowei Zhong, Hui Wang, et al.
Circulation. Arrhythmia and Electrophysiology|November 11, 2014
Telomere length and the risk of atrial fibrillation: insights into the role of biological versus chronological agingJason D Roberts, Thomas A Dewland, James Longoria, et al.
Circulation. Cardiovascular Genetics|February 16, 2017
Novel Variant in the <i>ANK2</i> Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT SyndromeLeigh Anne Swayne, Nathaniel P Murphy, Sirisha Asuri, et al.
Circulation. Arrhythmia and Electrophysiology|September 21, 2021
Human RyR2 (Ryanodine Receptor 2) Loss-of-Function Mutations: Clinical Phenotypes and In Vitro CharacterizationYanhui Li, Jinhong Wei, Wenting Guo, et al.
Frontiers in Cardiovascular Medicine|May 31, 2023
Perceived self-efficacy and empowerment in patients at increased risk of sudden cardiac arrestBrianna Davies, Katherine S Allan, Sandra L Carroll, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 8, 2021
Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in 'lone' atrial fibrillationJulieta Lazarte, Zachary W Laksman, Jian Wang, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease ModelsKate Huang, Mishal Ashraf, Leili Rohani, et al.
Heart Rhythm|October 16, 2022
Incremental value of the signal-averaged ECG for diagnosing arrhythmogenic cardiomyopathyCharles Michael Pearman, David Lee, Brianna Davies, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|April 3, 2012
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trialJason D Roberts, George A Wells, Michel R Le May, et al.
Heart Rhythm|March 7, 2015
Comparison of radionuclide angiographic synchrony analysis to echocardiography and magnetic resonance imaging for the diagnosis of arrhythmogenic right ventricular cardiomyopathyColleen J Johnson, Jason D Roberts, Jameze H James, et al.
The Biochemical Journal|July 26, 2023
RyR2 C-terminal truncating variants identified in patients with arrhythmic phenotypes exert a dominant negative effect through formation of wildtype-truncation heteromersShanshan Tian, Xiaowei Zhong, Hui Wang, et al.
Circulation. Arrhythmia and Electrophysiology|November 11, 2014
Telomere length and the risk of atrial fibrillation: insights into the role of biological versus chronological agingJason D Roberts, Thomas A Dewland, James Longoria, et al.
Circulation. Cardiovascular Genetics|February 16, 2017
Novel Variant in the <i>ANK2</i> Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT SyndromeLeigh Anne Swayne, Nathaniel P Murphy, Sirisha Asuri, et al.
Circulation. Arrhythmia and Electrophysiology|September 21, 2021
Human RyR2 (Ryanodine Receptor 2) Loss-of-Function Mutations: Clinical Phenotypes and In Vitro CharacterizationYanhui Li, Jinhong Wei, Wenting Guo, et al.
Frontiers in Cardiovascular Medicine|May 31, 2023
Perceived self-efficacy and empowerment in patients at increased risk of sudden cardiac arrestBrianna Davies, Katherine S Allan, Sandra L Carroll, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 8, 2021
Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in 'lone' atrial fibrillationJulieta Lazarte, Zachary W Laksman, Jian Wang, et al.
Circulation. Genomic and Precision Medicine|January 24, 2025
Atrial Fibrillation Related Titin Truncation Is Associated With Atrial Myopathy in Patient-Derived Induced Pluripotent Stem Cell Disease ModelsKate Huang, Mishal Ashraf, Leili Rohani, et al.
Heart Rhythm|October 16, 2022
Incremental value of the signal-averaged ECG for diagnosing arrhythmogenic cardiomyopathyCharles Michael Pearman, David Lee, Brianna Davies, et al.
Pageof 16